Reliwell Pharmaceutical Private Limited
About Reliwell Pharmaceutical Private Limited
Data last updated:
Reliwell Pharmaceutical Private Limited is a private limited company based in Panipat, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 August 2023.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U46497HR2023PTC114554.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neeru Bhatia and Deepak Bhatia.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Panipat, Haryana.
Company details
Contact details
Reliwell Pharmaceutical Private Limited's registered office is in Panipat, Haryana.
- Registered AddressHouse No. 409, Sector – 18 HUDA, Panipat, Haryana, India – 132103
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Reliwell Pharmaceutical Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Reliwell Pharmaceutical Private Limited, buy the company report.
Board of directors of Reliwell Pharmaceutical Private Limited
Reliwell Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeru Bhatia | Director | 30 Aug 2023 | 3 Years 2 Months | Current |
| Deepak Bhatia Also directs: A2y Exports Private Limited | Director | 30 Aug 2023 | 3 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Reliwell Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Reliwell Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Reliwell Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Reliwell Pharmaceutical Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Rajat Sehra was appointed as Additional Director on 28 May 2025.
Frequently asked questions
Reliwell Pharmaceutical is an active private limited company based in Panipat, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 August 2023 (3+ years old) and is registered under CIN U46497HR2023PTC114554.
Reliwell Pharmaceutical has 2 current directors:
- Neeru Bhatia - Director
- Deepak Bhatia - Director
The latest financial statements of Reliwell Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Reliwell Pharmaceutical is U46497HR2023PTC114554. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Reliwell Pharmaceutical was incorporated on 30 August 2023, making it 3+ years old. It is registered with the Registrar of Companies, Haryana.
Rajat Sehra was appointed as Additional Director on 28 May 2025. Deepak Bhatia was appointed as Director on 30 Aug 2023. Neeru Bhatia was appointed as Director on 30 Aug 2023.
The registered office of Reliwell Pharmaceutical is at House No. 409, Sector – 18 HUDA, Panipat, Haryana, India – 132103.
Reliwell Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Reliwell Pharmaceutical can be reached at its registered office: House No. 409, Sector – 18 HUDA, Panipat, Haryana, India – 132103.
Reliwell Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Haryana.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
